#1 Clinical Trials Search in Europe

Olanzapine

Olanzapine, also known by the brand name Zyprexa, is an antipsychotic medication that has been the subject of numerous clinical trials. These studies aim to evaluate its effectiveness and safety in treating various mental health conditions, as well as its potential applications in other areas of medicine. This article summarizes key findings from clinical trials investigating olanzapine’s use in schizophrenia, bipolar disorder, autism, and chemotherapy-induced nausea and vomiting.

Table of Contents

What is Olanzapine?

Olanzapine is a medication that belongs to a class of drugs called atypical antipsychotics. It is widely known by its brand name Zyprexa[1]. This medication is used to treat various mental health conditions and has been the subject of numerous clinical trials to evaluate its effectiveness and safety[2].

Conditions Treated with Olanzapine

Olanzapine is primarily used to treat the following conditions:

  • Schizophrenia: A severe mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behavior[3].
  • Bipolar Disorder: A mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression)[4].
  • Acute Agitation: A state of extreme restlessness and emotional distress often associated with psychiatric conditions[5].

Additionally, research is ongoing to explore the use of olanzapine in other conditions:

  • Autism: A developmental disorder that affects communication and behavior[6].
  • Chemotherapy-Induced Nausea and Vomiting: Olanzapine is being studied as a potential treatment to prevent nausea and vomiting in cancer patients undergoing chemotherapy[7].

How Olanzapine Works

Olanzapine works by affecting certain chemicals in the brain, primarily dopamine and serotonin. These chemicals, also known as neurotransmitters, play crucial roles in regulating mood, behavior, and thought processes[8]. By modulating the activity of these neurotransmitters, olanzapine helps to alleviate symptoms associated with various mental health conditions.

Dosage Forms and Administration

Olanzapine is available in several forms:

  • Oral tablets: These are the most common form, typically taken once or twice daily[9].
  • Orally disintegrating tablets (Zydis): These tablets dissolve quickly in the mouth and are useful for patients who have difficulty swallowing[5].
  • Intramuscular injection (IM): Used for rapid treatment of acute agitation[5].
  • Long-acting injection (Olanzapine Pamoate Depot): Administered every 2-4 weeks for long-term treatment[3].

The dosage of olanzapine varies depending on the condition being treated and the individual patient’s response. It’s crucial to take olanzapine exactly as prescribed by your healthcare provider.

Effectiveness of Olanzapine

Clinical trials have shown that olanzapine can be effective in treating various mental health conditions:

  • In schizophrenia, olanzapine has been shown to improve symptoms such as hallucinations, delusions, and disorganized thinking[3].
  • For bipolar disorder, olanzapine can help manage manic episodes and may be used in combination with other medications for maintenance treatment[4].
  • In acute agitation, rapid-acting forms of olanzapine can help calm patients quickly[5].

The effectiveness of olanzapine can vary from person to person, and it may take several weeks to see the full benefits of the medication.

Side Effects and Safety Considerations

Like all medications, olanzapine can cause side effects. Some common side effects include:

  • Weight gain and increased appetite
  • Drowsiness or sedation
  • Dizziness
  • Dry mouth
  • Constipation

More serious side effects, though less common, can include:

  • Increased blood sugar levels, which may lead to or worsen diabetes
  • High cholesterol levels
  • Changes in heart rhythm
  • Increased risk of stroke in elderly patients with dementia-related psychosis

It’s important to discuss any side effects with your healthcare provider. Regular monitoring of weight, blood sugar, and cholesterol levels is typically recommended for patients taking olanzapine[3].

Ongoing Research and Future Applications

Researchers continue to study olanzapine to better understand its effects and explore new potential uses:

  • Studies are investigating the use of olanzapine in combination with other medications for enhanced effectiveness in treating mental health conditions[8].
  • Research is ongoing to determine the optimal dosage of olanzapine for preventing chemotherapy-induced nausea and vomiting in cancer patients[7].
  • Long-term studies are being conducted to assess the safety and effectiveness of olanzapine in children with autism[6].

As research progresses, our understanding of olanzapine and its potential applications continues to grow, potentially leading to improved treatments for various conditions in the future.

Aspect Details
Conditions Studied Schizophrenia, Bipolar Disorder, Autism, Chemotherapy-Induced Nausea and Vomiting
Dosage Forms Oral tablets, Orally disintegrating wafers, Intramuscular injections, Nasal spray (experimental)
Dose Ranges 2.5 mg to 20 mg daily, with variations based on condition and study design
Primary Outcome Measures PANSS, CGI-S, YMRS, Quality of Life scales, Safety assessments
Study Durations Short-term (few weeks) to long-term (up to 104 weeks)
Notable Side Effects Weight gain, Increased blood glucose, Elevated prolactin levels, Sedation
Comparators Placebo, Other antipsychotics (e.g., haloperidol), Standard treatments
Special Populations Children with autism, Cancer patients, Healthy volunteers (for bioequivalence studies)

FAQ

  • What conditions is olanzapine being studied for in clinical trials? Clinical trials are investigating olanzapine for various conditions, including schizophrenia, bipolar disorder, autism, and chemotherapy-induced nausea and vomiting. It is being studied both as a primary treatment and as an add-on therapy to existing treatments.
  • How is olanzapine administered in these trials? Olanzapine is administered in various forms across different trials. These include oral tablets (ranging from 2.5 mg to 20 mg), orally disintegrating wafers, intramuscular injections, and even as a nasal spray in some experimental studies.
  • What are some of the primary outcomes measured in olanzapine trials? Primary outcomes often include changes in symptom severity scales specific to the condition being studied, such as the Positive and Negative Syndrome Scale (PANSS) for schizophrenia or the Young Mania Rating Scale (YMRS) for bipolar disorder. Other common measures include overall clinical improvement, quality of life assessments, and safety evaluations.
  • Are there any notable side effects of olanzapine observed in these trials? Some side effects noted in olanzapine trials include weight gain, increased blood glucose levels, and elevated prolactin levels. Sedation or sleepiness is also commonly reported, especially at higher doses. However, the specific side effect profile can vary depending on the dosage and the condition being treated.
  • How long do typical olanzapine clinical trials last? The duration of olanzapine trials varies widely depending on the study objectives. Some short-term studies last only a few weeks, while long-term safety and efficacy trials can extend up to 104 weeks (2 years) or more. Many trials include both acute treatment phases and longer-term follow-up periods.

Ongoing Clinical Trials on Olanzapine

  • Study of Selinexor, Dexamethasone, and Bortezomib for Patients with Refractory Multiple Myeloma

    Recruiting

    1 1 1
    Investigated drugs:
    Greece

  • Study Comparing Trastuzumab Deruxtecan with Standard Treatment for Patients with HER2-positive Breast Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Norway Sweden

  • Study on the Effects of Dexamethasone and Olanzapine in Patients Resuscitated from Out-of-Hospital Cardiac Arrest

    Recruiting

    1 1 1
    Investigated drugs:
    Denmark

  • Study on Dexamethasone and Olanzapine for Patients Undergoing Heart Surgery

    Recruiting

    1 1 1
    Investigated drugs:
    Denmark

  • Study on Continuing or Reducing Antipsychotic Medication (Haloperidol, Clozapine, Tiapride) for Patients After First Episode of Psychosis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of Azenosertib (ZN-c3) for Women with Recurrent or Persistent Uterine Serous Carcinoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain

  • Study on the Safety and Effectiveness of Olanzapine for Patients with Schizophrenia

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

Glossary

  • Olanzapine: An antipsychotic medication used to treat schizophrenia, bipolar disorder, and other mental health conditions. It is also known by the brand name Zyprexa.
  • Schizophrenia: A serious mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behavior.
  • Bipolar Disorder: A mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression).
  • PANSS (Positive and Negative Syndrome Scale): A medical scale used for measuring symptom severity of patients with schizophrenia. It includes assessments of positive symptoms, negative symptoms, and general psychopathology.
  • CGI-S (Clinical Global Impression – Severity): A 7-point scale used by healthcare professionals to rate the severity of a patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis.
  • Pharmacokinetics (PK): The study of how a drug is absorbed, distributed, metabolized, and excreted by the body over time.
  • Pharmacodynamics (PD): The study of the biochemical and physiological effects of drugs on the body and the mechanisms of drug action.
  • Bioequivalence: The absence of a significant difference in the rate and extent to which the active ingredient in pharmaceutical equivalents becomes available at the site of drug action when administered at the same dose under similar conditions.
  • Chemotherapy-Induced Nausea and Vomiting (CINV): Nausea and vomiting that occurs as a side effect of chemotherapy treatment for cancer.
  • Autologous Stem Cell Transplantation: A procedure in which a patient's own stem cells are removed, stored, and later given back to the patient as part of cancer treatment.

References

  1. https://clinicaltrials.gov/study/NCT03631004
  2. https://clinicaltrials.gov/study/NCT01990755
  3. https://clinicaltrials.gov/study/NCT00320489
  4. https://clinicaltrials.gov/study/NCT00186017
  5. https://clinicaltrials.gov/study/NCT03624322
  6. https://clinicaltrials.gov/study/NCT00183404
  7. https://clinicaltrials.gov/study/NCT06588413
  8. https://clinicaltrials.gov/study/NCT02137993
  9. https://clinicaltrials.gov/study/NCT01503424